ASRS
RYTM icon

Arizona State Retirement System’s Rhythm Pharmaceuticals RYTM Stock Holding History

Arizona State Retirement System’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.36M Sell
15,581
-181
-1% -$17.6K 0.01% 927
2025
Q4 		$1.69M Buy
15,762
+148
+0.9% +$15.7K 0.01% 836
2025
Q3 		$1.58M Buy
15,614
+1,780
+13% +$165K 0.01% 911
2025
Q2 		$874K Buy
13,834
+653
+5% +$40K 0.01% 1167
2025
Q1 		$698K Sell
13,181
-106
-0.8% -$5.88K ﹤0.01% 1250
2024
Q4 		$744K Buy
13,287
+119
+0.9% +$6.57K ﹤0.01% 1282
2024
Q3 		$690K Buy
13,168
+541
+4% +$25.9K ﹤0.01% 1312
2024
Q2 		$518K Sell
12,627
-366
-3% -$14.6K ﹤0.01% 1406
2024
Q1 		$563K Buy
12,993
+267
+2% +$11.7K ﹤0.01% 1368
2023
Q4 		$585K Sell
12,726
-224
-2% -$7.07K ﹤0.01% 1357
2023
Q3 		$297K Buy
12,950
+199
+2% +$4.46K ﹤0.01% 1670
2023
Q2 		$210K Sell
12,751
-310
-2% -$5.6K ﹤0.01% 1933
2023
Q1 		$233K Buy
13,061
+1,612
+14% +$40.5K ﹤0.01% 1851
2022
Q4 		$333K Buy
11,449
+1,178
+11% +$30.3K ﹤0.01% 1607
2022
Q3 		$252K Buy
10,271
+41
+0.4% +$762 ﹤0.01% 1745
2022
Q2 		$42K Buy
+10,230
New +$56K ﹤0.01% 2213
2021
Q2 		– Sell
-10,027
Closed -$213K – 2241
2021
Q1 		$213K Buy
10,027
+2,986
+42% +$86.6K ﹤0.01% 2010
2020
Q4 		$209K Buy
+7,041
New +$179K ﹤0.01% 1933

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Arizona State Retirement System's RYTM Position: Q1 2026 in Review

Arizona State Retirement System reduced its Rhythm Pharmaceuticals (RYTM) stake by 1.1% in Q1 2026, selling an estimated $17.6K and leaving 15,581 shares worth $1.36M. The position accounts for 0.01% of the portfolio, ranked #927.

Arizona State Retirement System first reported a position in RYTM in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.69M in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Arizona State Retirement System held 15,581 shares of Rhythm Pharmaceuticals worth $1.36M as of Q1 2026.
  • Arizona State Retirement System sold 181 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $17.6K.
  • Rhythm Pharmaceuticals made up 0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #927 holding.
  • Arizona State Retirement System first reported a position in Rhythm Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • Arizona State Retirement System's Rhythm Pharmaceuticals position peaked at $1.69M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.